
About 10 million US children and young adults aged 2-24 are on medication for attention deficit hyperactivity disorder (ADHD) – and 40 per cent of those are on multiple psychotropic drugs, including antipsychotics, according to Gretchen Watson, a clinical psychologist and researcher















